Entasis Therapeutics Holdings Inc. Shares Close the Week 20.2% Higher - Weekly Wrap

The company saw its shares close the week 20.2% higher than last week, with trading volume lower than its 30 day average.

Mar 12, 2021 by Kwhen Finance Editors

Entasis Therapeutics Holdings Inc. Shares Close the Week 20.2% Higher - Weekly Wrap
Entasis Therapeutics Holdings Inc. shares closed this week 20.2% higher than it did at the end of last week. The stock is currently up 23.1% year-to-date, up 12.6% over the past 12 months, and down 71.5% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%.

Trading Activity

  • Shares traded as high as $3.14 and as low as $2.54 this week.
  • Shares closed 5e+1% below its 52-week high and 9e+1% above its 52-week low.
  • Trading volume this week was 16.3% higher than the 10-day average and 6.1% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at -0.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Entasis Therapeutics Holdings Inc.7.423.112.6-49.381.0
Dow Jones Industrial Average0.57.644.40.284.0
S&P 500 Index0.65.449.0-0.383.0
Health Care0.72.032.3-4.260.7

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 137.8%
  • The company's stock price performance over the past 12 months beats the peer average by 9.7%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Entasis Therapeutics Holdings Inc.ETTX023.112.6-49.381.0
Peer AvgN/A-2.29.711.5-18.946.2
Omeros CorporationOMER-8.939.463.1-16.5132.6
Odonate Therapeutics Inc.ODT0-0.6-17.2-58.952.1

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: